CLINICAL_TRIALS
trial_result
· 2014-09-17
Clinical Trial Update: Schistosoma Mansoni Morbidity in Children Aged 1-5 Years [Phase 2]
Summary
A Phase 2 clinical trial evaluating morbidity from Schistosoma mansoni infection in children aged 1-5 years has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Makerere University | Conditions: Intestinal Schistosomiasis | Phase 2 | Status: COMPLETED